Amanta Healthcare share news, announcements and annual reports
NSE: AMANTABSE: 544502Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹160.34.
29 Oct: open ₹161.01, high ₹178.57, low ₹161.01
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹664 Cr1,889th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.21
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 38.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 6.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 7.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,55,84744.8% delivered
Amanta Healthcare share news and announcements
150 announcements, routine notices left out, newest first. Page 2 of 3.
Jun 2026
May 2026
30 May
29 May · Business
29 May · Business
29 May · Business
29 May · Business
19 May · Revision In Remuneration Of Managing Director - Recommended By Board Of Directors
19 May · Management
19 May
19 May · Management
19 May · Results
19 May · Business
19 May
19 May · Results
19 May · Board meeting
16 May · Analysts
15 May · Business
11 May · Board meeting
Apr 2026
16 Apr · Management
9 Apr · Updates
9 Apr · Analysts
9 Apr · Analysts
2 Apr · Analysts
1 Apr · Updates
1 Apr · Open Market Purchase Of Equity Shares By Promoter
Mar 2026
26 Mar · Open Market Purchase Of Equity Shares By Immediate Relative Of Director
Feb 2026
27 Feb · Open Market Purchase Of Equity Shares By Promoter
16 Feb · Rating
16 Feb · Rating
14 Feb · Business